Business Update26 Aug 2024, 06:08 pm
Lilac Investments Acquires 7.27% Stake in Eris Lifesciences Ltd
AI Summary
Lilac Investments Limited has purchased 98,86,882 equity shares of Eris Lifesciences Limited, a company listed on the BSE Limited and the National Stock Exchange of India Limited. This acquisition amounts to 7.27% of the total share capital and 7.27% of the total diluted share capital of Eris Lifesciences Limited. Lilac Investments Limited did not hold any shares or voting rights in Eris Lifesciences Limited before this acquisition. This acquisition does not involve any warrants, convertible securities, or other instruments that entitle the acquirer to receive shares carrying voting rights in Eris Lifesciences Limited.
Key Highlights
- Lilac Investments Limited acquires 7.27% stake in Eris Lifesciences Limited
- This acquisition involves 98,86,882 equity shares of Eris Lifesciences Limited
- Eris Lifesciences Limited is listed on the BSE Limited and the National Stock Exchange of India Limited
- Before the acquisition, Lilac Investments Limited did not hold any shares or voting rights in Eris Lifesciences Limited
- This acquisition does not involve any warrants, convertible securities, or other instruments that entitle the acquirer to receive shares carrying voting rights in Eris Lifesciences Limited